• Recorded Webinar
  • On-Demand
In this webinar, Dr Carl Lavie will discuss the adverse effects that obesity has on the major CVD risk factors and to increase almost all CVD.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Nutrition Therapy
This interactive session will explore the complex relationship of how our mood affects our food choices and vice versa.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Nutrition Therapy
This session will discuss the benefits of a carbohydrate-restricted diet on chronic diseases such as type 2 diabetes with special attention on the role of nutrition in wound healing.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
The gut microbiome is recognized as an important factor in obesity. This webinar will review the interconnection between obesity and the gut microbiome.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Behavioral Modification
In this webinar, Dr. Puhl will provide an overview of the nature of weight stigma affecting youth and adults with obesity.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Nutrition Therapy
Nutrition is one of the pillars of obesity treatment. While clinicians are easily able to advise patients what NOT to eat, telling patients what to eat can be harder.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Treatment Strategies
This webinar provides a brief overview of how we can incorporate technology into nutrition and medical weight loss.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pharmacotherapy
Dr. Weber will present and discuss case examples that will increase familiarity with antiobesity medication indications, contraindications, side effect profiles, and medication interactions.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pharmacotherapy
This webinar re-playing the popular session from the Obesity Medicine Conference 2021 provides a brief overview of FDA-approved anti-obesity medications (AOM’s).
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Physical Activity
This session will review obesity as a chronic low-grade inflammatory state predisposing to chronic diseases including CAD/CVD and COVID-19 complications.
  • 1.00 AMA PRA Category 1 Credit

Pages